<?xml version='1.0' encoding='UTF-8'?>
<article doi="10.15252/emmm.201404914"><fig id="6948"><title>Clinical response of patient M032 to vemurafenib.</title><label>Figure 1</label><graphic href="https://api.sourcedata.io/file.php?figure_id=6948"/><sd-panel panel_id="21473"><p>Treatment schedule of <sd-pretag id="sdPretag14585439891180" parent-tag-id="38">patient</sd-pretag> M032, who received a PET scan two weeks before the start of the treatment (purple asterisk), followed by a baseline CT scan and every two months a follow-up CT scan (red asterisks). Metastases were surgically removed either shortly before the start of the treatment or after resistance occurred (post, M032R1-R5). PR, partial response; PD, progressive disease. Locations of the removed metastases are indicated in the illustration.</p> <graphic href="https://api.sourcedata.io/file.php?panel_id=21473"/></sd-panel><sd-panel panel_id="21474"><p>Examples of <sd-tag id="sdTag1" source="sdapi" category="assay" entity_type="None" role="None" text="CT scan" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">CT scan</sd-tag> images of several <sd-tag id="sdTag179" source="sdapi" category="None" entity_type="tissue" role="assayed" text="metastases" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">metastases</sd-tag> (M032R1, M032R2, and M032R5).</p> <graphic href="https://api.sourcedata.io/file.php?panel_id=21474"/></sd-panel><sd-panel panel_id="21475"><p>Volumetric measurements based on the <sd-tag id="sdTag5" source="sdapi" category="assay" entity_type="None" role="None" text="PET" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">PET</sd-tag> and <sd-tag id="sdTag6" source="sdapi" category="assay" entity_type="None" role="None" text="CT scans" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">CT scans</sd-tag> could be generated from M032, M032R1, and M032R5. Graph illustrates that the <sd-tag id="sdTag180" source="sdapi" category="None" entity_type="tissue" role="assayed" text="metastases" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">metastases</sd-tag> R1 and R5 initially expanded before the start of the treatment, but regressed upon <sd-tag id="sdTag143" source="sdapi" category="None" entity_type="molecule" role="intervention" text="vemurafenib" ext_ids="CHEBI:63637" ext_dbs="" in_caption="True" ext_names="vemurafenib" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">vemurafenib</sd-tag> treatment. M032R5 showed progressive disease after 4 months, whereas M032R1 still displayed stable disease. M032 was excised and no recurrence was observed.</p> <graphic href="https://api.sourcedata.io/file.php?panel_id=21475"/></sd-panel></fig><fig id="6949"><title>Reactivation of MAPK pathway via amplification of a BRAF-encoding DNA fragment caused resistance to vemurafenib in three metastases.</title><label>Figure 2</label><graphic href="https://api.sourcedata.io/file.php?figure_id=6949"/><sd-panel panel_id="21476"><span><sd-tag id="sdTag13" source="sdapi" category="assay" entity_type="None" role="None" text="Hematoxylin–eosin (H&amp;E)" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">Hematoxylin-eosin (H&amp;amp;amp;E)</sd-tag> and p-</span><span><sd-tag id="sdTag14" source="sdapi" category="None" entity_type="protein" role="assayed" text="ERK" ext_ids="P28482///P27361" ext_dbs="" in_caption="True" ext_names="MAPK1///MAPK3" ext_tax_ids="9606///9606" ext_tax_names="Homo sapiens///Homo sapiens" ext_urls="https://www.uniprot.org/uniprot////https://www.uniprot.org/uniprot/">ERK</sd-tag></span> stainings on FFPE material of all <span><sd-tag id="sdTag181" source="sdapi" category="None" entity_type="tissue" role="assayed" text="metastases" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">metastases</sd-tag></span> <span>showed that all <sd-tag id="sdTag15" source="sdapi" category="None" entity_type="molecule" role="intervention" text="vemurafenib" ext_ids="CHEBI:63637" ext_dbs="" in_caption="True" ext_names="vemurafenib" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">vemurafenib</sd-tag>-resistant</span> <sd-tag id="sdTag17" source="sdapi" category="None" entity_type="tissue" role="assayed" text="tumors" ext_ids="UBERON:0000479" ext_dbs="" in_caption="True" ext_names="tissue" ext_tax_ids="" ext_tax_names="" ext_urls="https://www.ebi.ac.uk/ols/ontologies/uberon/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FUBERON_">tumors</sd-tag> had reactivation of the MAPK pathway. Scale bar represents 100 μm <graphic href="https://api.sourcedata.io/file.php?panel_id=21476"/></sd-panel><sd-panel panel_id="21477"><p>CNA profiles were generated from the WES data with germ line DNA as a reference. Colors represent segmented log2 ratio values with red for gain and blue for loss. Further inspection of <sd-pretag id="sdPretag14569310167490" type="subcellular" role="experiment" category="null" class="experiment subcellular">chromosome</sd-pretag> 7 where <sd-pretag id="sdPretag14569310310040" type="gene" role="component" category="null" class="component gene">BRAF</sd-pretag> is located revealed amplification (7q34) of this region in three <sd-pretag id="sdPretag14569324515260" parent-tag-id="15" class="component molecule">vemurafenib</sd-pretag>-resistant <sd-pretag id="sdPretag14569309492820" type="tissue" role="component" category="null" class="component tissue">metastases</sd-pretag>, namely M032R1, M032R2, and M032R5.</p> <graphic href="https://api.sourcedata.io/file.php?panel_id=21477"/></sd-panel><sd-panel panel_id="21478"><p><sd-tag id="sdTag20" source="sdapi" category="assay" entity_type="None" role="None" text="qPCR" ext_ids="BAO_0002084" ext_dbs="" in_caption="True" ext_names="real-time PCR " ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">qPCR</sd-tag> was performed on <sd-tag id="sdTag18" source="sdapi" category="None" entity_type="molecule" role="component" text="gDNA" ext_ids="CHEBI:4705" ext_dbs="" in_caption="True" ext_names="double-stranded DNA" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">gDNA</sd-tag> retrieved from each of the <sd-tag id="sdTag182" source="sdapi" category="None" entity_type="tissue" role="component" text="metastases" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">metastases</sd-tag>, using primers for <sd-tag id="sdTag21" source="sdapi" category="None" entity_type="gene" role="assayed" text="BRAF" ext_ids="673" ext_dbs="" in_caption="True" ext_names="BRAF" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRAF</sd-tag> and <sd-tag id="sdTag19" source="sdapi" category="None" entity_type="gene" role="assayed" text="CRAF" ext_ids="5894" ext_dbs="" in_caption="True" ext_names="RAF1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">CRAF</sd-tag> and normalized on LINE levels. Bars represent the mean of three replicates, error bars indicate standard deviation. The results confirmed that <sd-tag id="sdTag22" source="sdapi" category="None" entity_type="gene" role="assayed" text="BRAF" ext_ids="673" ext_dbs="" in_caption="True" ext_names="BRAF" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRAF</sd-tag> was amplified in M032R1, M032R2, and M032R5.</p> <graphic href="https://api.sourcedata.io/file.php?panel_id=21478"/></sd-panel><sd-panel panel_id="21479"><p><sd-tag id="sdTag24" source="sdapi" category="assay" entity_type="None" role="None" text="Staining" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">Staining</sd-tag> for <sd-tag id="sdTag26" source="sdapi" category="None" entity_type="protein" role="assayed" text="BRAF" ext_ids="P15056" ext_dbs="" in_caption="True" ext_names="BRAF" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://www.uniprot.org/uniprot/">BRAF</sd-tag><sup>V600E</sup> with a mutant epitope-specific antibody confirmed the upregulation of <sd-tag id="sdTag25" source="sdapi" category="None" entity_type="protein" role="assayed" text="BRAF" ext_ids="P15056" ext_dbs="" in_caption="True" ext_names="BRAF" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://www.uniprot.org/uniprot/">BRAF</sd-tag><sup>V600E</sup> in R1, R2, and R5. Scale bar represents 100 μm.</p> <graphic href="https://api.sourcedata.io/file.php?panel_id=21479"/></sd-panel></fig><fig id="6950"><title>Alternative form of BRAFV600E is correlated with p-ERK and p-MEK reactivation in M032R3.</title><label>Figure 3</label><graphic href="https://api.sourcedata.io/file.php?figure_id=6950"/><sd-panel panel_id="21480"><sd-tag id="sdTag30" source="sdapi" category="assay" entity_type="None" role="None" text="Immunoblotting" ext_ids="BAO_0002424" ext_dbs="" in_caption="True" ext_names="western blot" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">Immunoblotting</sd-tag> for MAPK pathway components confirmed reactivation of p-<span><sd-tag id="sdTag29" source="sdapi" category="None" entity_type="protein" role="assayed" text="ERK" ext_ids="P28482///P27361" ext_dbs="" in_caption="True" ext_names="MAPK1///MAPK3" ext_tax_ids="9606///9606" ext_tax_names="Homo sapiens///Homo sapiens" ext_urls="https://www.uniprot.org/uniprot////https://www.uniprot.org/uniprot/">ERK</sd-tag></span> <span>and p-<sd-tag id="sdTag28" source="sdapi" category="None" entity_type="protein" role="assayed" text="MEK" ext_ids="P36507///Q02750" ext_dbs="" in_caption="True" ext_names="MAP2K2///MAP2K1" ext_tax_ids="9606///9606" ext_tax_names="Homo sapiens///Homo sapiens" ext_urls="https://www.uniprot.org/uniprot////https://www.uniprot.org/uniprot/">MEK</sd-tag> in all resistant</span> <span><sd-tag id="sdTag183" source="sdapi" category="None" entity_type="tissue" role="component" text="metastases" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">metastases</sd-tag></span>. <graphic href="https://api.sourcedata.io/file.php?panel_id=21480"/></sd-panel><sd-panel panel_id="21481"><p><sd-tag id="sdTag37" source="sdapi" category="assay" entity_type="None" role="None" text="Immunoblotting" ext_ids="BAO_0002424" ext_dbs="" in_caption="True" ext_names="western blot" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">Immunoblotting</sd-tag> for M032 <sd-tag id="sdTag38" source="sdapi" category="None" entity_type="organism" role="component" text="patient" ext_ids="9606" ext_dbs="" in_caption="True" ext_names="Homo sapiens" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ncbi.nlm.nih.gov/taxonomy/">patient</sd-tag>'s samples using an antibody directed against either the mutant <sd-tag id="sdTag39" source="sdapi" category="None" entity_type="protein" role="assayed" text="BRAF" ext_ids="P15056" ext_dbs="" in_caption="True" ext_names="BRAF" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://www.uniprot.org/uniprot/">BRAF</sd-tag><sup>V600E</sup> epitope or an N-terminal region of <sd-tag id="sdTag40" source="sdapi" category="None" entity_type="protein" role="assayed" text="BRAF" ext_ids="P15056" ext_dbs="" in_caption="True" ext_names="BRAF" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://www.uniprot.org/uniprot/">BRAF</sd-tag> revealed the expression of a shorter variant of <sd-tag id="sdTag36" source="sdapi" category="None" entity_type="protein" role="assayed" text="BRAF" ext_ids="P15056" ext_dbs="" in_caption="True" ext_names="BRAF" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://www.uniprot.org/uniprot/">BRAF</sd-tag><sup>V600E</sup> in M032R3, of approximately 80 kDa. This 80-kDa band could not be detected with the N-terminus-recognizing antibody.</p> <graphic href="https://api.sourcedata.io/file.php?panel_id=21481"/></sd-panel></fig><fig id="6951"><title>T55delinsRT mutation in MEK1 is responsible for resistance to vemurafenib in M032R4.</title><label>Figure 4</label><graphic href="https://api.sourcedata.io/file.php?figure_id=6951"/><sd-panel panel_id="21482">Somatic mutations present in each of these <sd-pretag id="sdPretag14569310710160" type="tissue" role="component" category="null">metastases</sd-pretag>, revealing that mutations were either shared by the pre-treatment <sd-pretag id="sdPretag14569310919690" type="tissue" role="experiment" category="null">tumor</sd-pretag> and all <sd-pretag id="sdPretag14569310710161" type="tissue" role="component" category="null">metastases</sd-pretag>, by some <sd-pretag id="sdPretag14569310710162" type="tissue" role="component" category="null">metastases</sd-pretag>, or only by single <sd-pretag id="sdPretag14569310710163" type="tissue" role="component" category="null">metastases</sd-pretag>. <graphic href="https://api.sourcedata.io/file.php?panel_id=21482"/></sd-panel><sd-panel panel_id="21483">A 3-bp in-frame insertion in MEK1 (T55delinsRT) was identified in M032R4. This mutation was located at the base of the α-helix at the N-terminal site of MEK1. <graphic href="https://api.sourcedata.io/file.php?panel_id=21483"/></sd-panel><sd-panel panel_id="21484">Validation of T55delinsRT was done by <sd-tag id="sdTag46" source="sdapi" category="assay" entity_type="None" role="None" text="PCR" ext_ids="BAO_0002080" ext_dbs="" in_caption="True" ext_names="polymerase chain reaction" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">PCR</sd-tag> using insertion-specific primers. As a control, primers amplifying exon 2 of <sd-tag id="sdTag47" source="sdapi" category="None" entity_type="gene" role="assayed" text="MEK1" ext_ids="5604" ext_dbs="" in_caption="True" ext_names="MAP2K1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">MEK1</sd-tag><sup>WT</sup> were used. <graphic href="https://api.sourcedata.io/file.php?panel_id=21484"/></sd-panel><sd-panel panel_id="21485"><span>Transfection of pQXCIP-<sd-tag id="sdTag188" source="sdapi" category="None" entity_type="gene" role="component" text="GFP" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">GFP</sd-tag>,</span> <sd-tag id="sdTag53" source="sdapi" category="None" entity_type="gene" role="intervention" text="MEK1" ext_ids="5604" ext_dbs="" in_caption="True" ext_names="MAP2K1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">MEK1</sd-tag>-WT, or <sd-tag id="sdTag54" source="sdapi" category="None" entity_type="gene" role="intervention" text="MEK1" ext_ids="5604" ext_dbs="" in_caption="True" ext_names="MAP2K1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">MEK1</sd-tag>-T55delinsRT into <sd-tag id="sdTag55" source="sdapi" category="None" entity_type="cell" role="component" text="HEK293T" ext_ids="CVCL_0063" ext_dbs="" in_caption="True" ext_names="HEK293T" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://identifiers.org/cellosaurus:">HEK293T</sd-tag> cells showed that this mutation induces p-<span><sd-tag id="sdTag51" source="sdapi" category="None" entity_type="protein" role="assayed" text="ERK" ext_ids="P28482///P27361" ext_dbs="" in_caption="True" ext_names="MAPK1///MAPK3" ext_tax_ids="9606///9606" ext_tax_names="Homo sapiens///Homo sapiens" ext_urls="https://www.uniprot.org/uniprot////https://www.uniprot.org/uniprot/">ERK</sd-tag></span> <span>and p-<sd-tag id="sdTag52" source="sdapi" category="None" entity_type="protein" role="assayed" text="RSK" ext_ids="P23443///Q15418" ext_dbs="" in_caption="True" ext_names="RPS6KB1///RPS6KA1" ext_tax_ids="9606///9606" ext_tax_names="Homo sapiens///Homo sapiens" ext_urls="https://www.uniprot.org/uniprot////https://www.uniprot.org/uniprot/">RSK</sd-tag>.</span> <graphic href="https://api.sourcedata.io/file.php?panel_id=21485"/></sd-panel><sd-panel panel_id="21486"><p>Validation of expression of pQXCIP-<sd-tag id="sdTag189" source="sdapi" category="None" entity_type="gene" role="component" text="GFP" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">GFP</sd-tag>, <sd-tag id="sdTag61" source="sdapi" category="None" entity_type="gene" role="intervention" text="MEK1" ext_ids="5604" ext_dbs="" in_caption="True" ext_names="MAP2K1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">MEK1</sd-tag><sup>WT</sup>, or <sd-tag id="sdTag62" source="sdapi" category="None" entity_type="gene" role="intervention" text="MEK1" ext_ids="5604" ext_dbs="" in_caption="True" ext_names="MAP2K1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">MEK1</sd-tag><sup>T55delinsRT</sup> in <sd-tag id="sdTag59" source="sdapi" category="None" entity_type="cell" role="component" text="A375" ext_ids="CVCL_0132" ext_dbs="" in_caption="True" ext_names="A-375" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://identifiers.org/cellosaurus:">A375</sd-tag> melanoma cells by <sd-tag id="sdTag63" source="sdapi" category="assay" entity_type="None" role="None" text="immunoblotting" ext_ids="BAO_0002424" ext_dbs="" in_caption="True" ext_names="western blot" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">immunoblotting</sd-tag>.</p> <graphic href="https://api.sourcedata.io/file.php?panel_id=21486"/></sd-panel><sd-panel panel_id="21487"><p>Dose-response curves for <sd-tag id="sdTag73" source="sdapi" category="None" entity_type="cell" role="assayed" text="A375" ext_ids="CVCL_0132" ext_dbs="" in_caption="True" ext_names="A-375" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://identifiers.org/cellosaurus:">A375</sd-tag> melanoma cells expressing <sd-tag id="sdTag190" source="sdapi" category="None" entity_type="gene" role="component" text="GFP" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">GFP</sd-tag>, <sd-tag id="sdTag75" source="sdapi" category="None" entity_type="gene" role="intervention" text="MEK1" ext_ids="5604" ext_dbs="" in_caption="True" ext_names="MAP2K1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">MEK1</sd-tag><sup>WT</sup>, or <sd-tag id="sdTag76" source="sdapi" category="None" entity_type="gene" role="intervention" text="MEK1" ext_ids="5604" ext_dbs="" in_caption="True" ext_names="MAP2K1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">MEK1</sd-tag><sup>T55delinsRT</sup> with indicated doses of <sd-tag id="sdTag77" source="sdapi" category="None" entity_type="gene" role="component" text="BRAF" ext_ids="673" ext_dbs="" in_caption="True" ext_names="BRAF" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRAF</sd-tag> inhibitor <sd-tag id="sdTag78" source="sdapi" category="None" entity_type="molecule" role="intervention" text="vemurafenib" ext_ids="CHEBI:63637" ext_dbs="" in_caption="True" ext_names="vemurafenib" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">vemurafenib</sd-tag>, <sd-tag id="sdTag82" source="sdapi" category="None" entity_type="gene" role="component" text="ERK" ext_ids="5595///5594" ext_dbs="" in_caption="True" ext_names="MAPK3///MAPK1" ext_tax_ids="9606///9606" ext_tax_names="Homo sapiens///Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene////http://www.ncbi.nlm.nih.gov/gene/">ERK</sd-tag> inhibitor <sd-tag id="sdTag70" source="sdapi" category="None" entity_type="molecule" role="intervention" text="SCH772984" ext_ids="24866313" ext_dbs="" in_caption="True" ext_names="SCH772984" ext_tax_ids="" ext_tax_names="" ext_urls="https://pubchem.ncbi.nlm.nih.gov/compound/">SCH772984</sd-tag>, or <sd-tag id="sdTag191" source="sdapi" category="None" entity_type="gene" role="component" text="MEK" ext_ids="5605///5604" ext_dbs="" in_caption="True" ext_names="MAP2K2///MAP2K1" ext_tax_ids="9606///9606" ext_tax_names="Homo sapiens///Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene////http://www.ncbi.nlm.nih.gov/gene/">MEK</sd-tag> inhibitor <sd-tag id="sdTag71" source="sdapi" category="None" entity_type="molecule" role="intervention" text="trametinib" ext_ids="CHEBI:75998" ext_dbs="" in_caption="True" ext_names="trametinib" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">trametinib</sd-tag>. Error bars indicate standard deviation.</p> <graphic href="https://api.sourcedata.io/file.php?panel_id=21487"/></sd-panel><sd-panel panel_id="21488"><p><sd-tag id="sdTag84" source="sdapi" category="assay" entity_type="None" role="None" text="Colony formation assays" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">Colony formation assays</sd-tag> with <sd-tag id="sdTag86" source="sdapi" category="None" entity_type="cell" role="assayed" text="A375" ext_ids="CVCL_0132" ext_dbs="" in_caption="True" ext_names="A-375" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://identifiers.org/cellosaurus:">A375</sd-tag> melanoma cells, infected with <sd-tag id="sdTag85" source="sdapi" category="None" entity_type="gene" role="component" text="GFP" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">GFP</sd-tag>, <sd-tag id="sdTag87" source="sdapi" category="None" entity_type="gene" role="intervention" text="MEK1" ext_ids="5604" ext_dbs="" in_caption="True" ext_names="MAP2K1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">MEK1</sd-tag><sup>WT</sup>, or <sd-tag id="sdTag88" source="sdapi" category="None" entity_type="gene" role="intervention" text="MEK1" ext_ids="5604" ext_dbs="" in_caption="True" ext_names="MAP2K1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">MEK1</sd-tag><sup>T55delinsRT</sup>-encoding lentivirus, and treated with indicated doses and inhibitors.</p> <graphic href="https://api.sourcedata.io/file.php?panel_id=21488"/></sd-panel><sd-panel panel_id="21489"><p>Treatment of <sd-tag id="sdTag98" source="sdapi" category="None" entity_type="cell" role="assayed" text="A375" ext_ids="CVCL_0132" ext_dbs="" in_caption="True" ext_names="A-375" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://identifiers.org/cellosaurus:">A375</sd-tag> <sd-tag id="sdTag99" source="sdapi" category="None" entity_type="gene" role="component" text="MEK1" ext_ids="5604" ext_dbs="" in_caption="True" ext_names="MAP2K1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">MEK1</sd-tag><sup>T55delinsRT</sup> melanoma cells with <sd-tag id="sdTag100" source="sdapi" category="None" entity_type="molecule" role="component" text="DMSO" ext_ids="CHEBI:28262" ext_dbs="" in_caption="True" ext_names="dimethyl sulfoxide" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">DMSO</sd-tag> (−), 250 nM <sd-tag id="sdTag97" source="sdapi" category="None" entity_type="molecule" role="intervention" text="dabrafenib" ext_ids="CHEBI:75045" ext_dbs="" in_caption="True" ext_names="dabrafenib" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">dabrafenib</sd-tag> (D), 10 nM <sd-tag id="sdTag101" source="sdapi" category="None" entity_type="molecule" role="intervention" text="trametinib" ext_ids="CHEBI:75998" ext_dbs="" in_caption="True" ext_names="trametinib" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">trametinib</sd-tag> (T), or a combination (D+T).</p> <graphic href="https://api.sourcedata.io/file.php?panel_id=21489"/></sd-panel></fig><fig id="6952"><title>T55delinsRT mutation in MEK1 confers resistance to BRAF inhibition and promotes local invasion in vivo.</title><label>Figure 5</label><graphic href="https://api.sourcedata.io/file.php?figure_id=6952"/><sd-panel panel_id="21490"><sd-tag id="sdTag104" source="sdapi" category="None" entity_type="cell" role="component" text="A375" ext_ids="CVCL_0132" ext_dbs="" in_caption="True" ext_names="A-375" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://identifiers.org/cellosaurus:">A375</sd-tag> melanoma cells expressing <span><sd-tag id="sdTag103" source="sdapi" category="None" entity_type="gene" role="component" text="GFP" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">GFP</sd-tag></span>, <sd-tag id="sdTag105" source="sdapi" category="None" entity_type="gene" role="intervention" text="MEK1" ext_ids="5604" ext_dbs="" in_caption="True" ext_names="MAP2K1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">MEK1</sd-tag><sup>WT</sup>, or <sd-tag id="sdTag106" source="sdapi" category="None" entity_type="gene" role="intervention" text="MEK1" ext_ids="5604" ext_dbs="" in_caption="True" ext_names="MAP2K1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">MEK1</sd-tag><sup>T55delinsRT</sup> were injected into immune-deficient <sd-tag id="sdTag107" source="sdapi" category="None" entity_type="organism" role="component" text="mice" ext_ids="10090" ext_dbs="" in_caption="True" ext_names="Mus musculus" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ncbi.nlm.nih.gov/taxonomy/">mice</sd-tag> (n = 8 per group), and after the <span><sd-tag id="sdTag110" source="sdapi" category="None" entity_type="tissue" role="assayed" text="tumor" ext_ids="UBERON:0000479" ext_dbs="" in_caption="True" ext_names="tissue" ext_tax_ids="" ext_tax_names="" ext_urls="https://www.ebi.ac.uk/ols/ontologies/uberon/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FUBERON_">tumor</sd-tag></span> size of ˜100 mm<sup>3</sup> was reached, <sd-tag id="sdTag108" source="sdapi" category="None" entity_type="organism" role="component" text="mice" ext_ids="10090" ext_dbs="" in_caption="True" ext_names="Mus musculus" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ncbi.nlm.nih.gov/taxonomy/">mice</sd-tag> were treated with 30 mg/kg <sd-tag id="sdTag109" source="sdapi" category="None" entity_type="molecule" role="intervention" text="dabrafenib" ext_ids="CHEBI:75045" ext_dbs="" in_caption="True" ext_names="dabrafenib" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">dabrafenib</sd-tag> or vehicle. Graphs represent fold change in <span><sd-tag id="sdTag111" source="sdapi" category="None" entity_type="tissue" role="assayed" text="tumor" ext_ids="UBERON:0000479" ext_dbs="" in_caption="True" ext_names="tissue" ext_tax_ids="" ext_tax_names="" ext_urls="https://www.ebi.ac.uk/ols/ontologies/uberon/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FUBERON_">tumor</sd-tag></span> volume normalized on the <span><sd-tag id="sdTag112" source="sdapi" category="None" entity_type="tissue" role="assayed" text="tumor" ext_ids="UBERON:0000479" ext_dbs="" in_caption="True" ext_names="tissue" ext_tax_ids="" ext_tax_names="" ext_urls="https://www.ebi.ac.uk/ols/ontologies/uberon/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FUBERON_">tumor</sd-tag></span> volume on the day of the start of the treatment. Error bars indicate standard error of the mean. <graphic href="https://api.sourcedata.io/file.php?panel_id=21490"/></sd-panel><sd-panel panel_id="21491"><p>Average <sd-tag id="sdTag115" source="sdapi" category="None" entity_type="tissue" role="assayed" text="tumor" ext_ids="UBERON:0000479" ext_dbs="" in_caption="True" ext_names="tissue" ext_tax_ids="" ext_tax_names="" ext_urls="https://www.ebi.ac.uk/ols/ontologies/uberon/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FUBERON_">tumor</sd-tag> weight of all groups at the end of the experiment described in (A). Error bars indicate standard deviation. Unpaired t-test was used to calculate statistical significance. P-values are indicated in the graph.</p> <graphic href="https://api.sourcedata.io/file.php?panel_id=21491"/></sd-panel><sd-panel panel_id="21492"><p><sd-tag id="sdTag122" source="sdapi" category="assay" entity_type="None" role="None" text="Immunoblotting" ext_ids="BAO_0002424" ext_dbs="" in_caption="True" ext_names="western blot" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">Immunoblotting</sd-tag> for MAPK pathway components performed on <sd-tag id="sdTag124" source="sdapi" category="None" entity_type="tissue" role="component" text="tumors" ext_ids="UBERON:0000479" ext_dbs="" in_caption="True" ext_names="tissue" ext_tax_ids="" ext_tax_names="" ext_urls="https://www.ebi.ac.uk/ols/ontologies/uberon/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FUBERON_">tumors</sd-tag> of all groups.</p> <graphic href="https://api.sourcedata.io/file.php?panel_id=21492"/></sd-panel><sd-panel panel_id="21493"><p><sd-tag id="sdTag138" source="sdapi" category="assay" entity_type="None" role="None" text="Immunohistochemistry" ext_ids="BAO_0000415" ext_dbs="" in_caption="True" ext_names="immunohistochemistry" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">Immunohistochemistry</sd-tag> for <sd-tag id="sdTag136" source="sdapi" category="assay" entity_type="None" role="None" text="Sirius Red" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">Sirius Red</sd-tag> (<sd-tag id="sdTag139" source="sdapi" category="assay" entity_type="None" role="None" text="staining" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">staining</sd-tag> for <sd-tag id="sdTag141" source="sdapi" category="None" entity_type="subcellular" role="assayed" text="collagen" ext_ids="GO:0098645" ext_dbs="" in_caption="True" ext_names="collagen network" ext_tax_ids="" ext_tax_names="" ext_urls="http://amigo.geneontology.org/amigo/term/">collagen</sd-tag>) and <sd-tag id="sdTag137" source="sdapi" category="assay" entity_type="None" role="None" text="H&amp;E" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">H&amp;amp;amp;E</sd-tag> on <sd-tag id="sdTag140" source="sdapi" category="None" entity_type="tissue" role="assayed" text="tumors" ext_ids="UBERON:0000479" ext_dbs="" in_caption="True" ext_names="tissue" ext_tax_ids="" ext_tax_names="" ext_urls="https://www.ebi.ac.uk/ols/ontologies/uberon/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FUBERON_">tumors</sd-tag> from all groups, to identify grade of demarcation and local invasion. Scale bar represents 500 (upper row) and 100 (lower row) μm.</p> <graphic href="https://api.sourcedata.io/file.php?panel_id=21493"/></sd-panel></fig><fig id="6953"><title>MEK1T55delinsRT is a preexisting mutation.</title><label>Figure 6</label><graphic href="https://api.sourcedata.io/file.php?figure_id=6953"/><sd-panel panel_id="21494"><h5>gDNA was isolated from another fragment of the <sd-tag id="sdTag146" source="sdapi" category="None" entity_type="tissue" role="component" text="tumor" ext_ids="UBERON:0000479" ext_dbs="" in_caption="True" ext_names="tissue" ext_tax_ids="" ext_tax_names="" ext_urls="https://www.ebi.ac.uk/ols/ontologies/uberon/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FUBERON_">tumor</sd-tag> resection, and the <sd-tag id="sdTag147" source="sdapi" category="assay" entity_type="None" role="None" text="PCR" ext_ids="BAO_0002080" ext_dbs="" in_caption="True" ext_names="polymerase chain reaction" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">PCR</sd-tag> with the insertion-specific primers was repeated. Primers amplifying exon 2 of <sd-tag id="sdTag148" source="sdapi" category="None" entity_type="gene" role="assayed" text="MEK1" ext_ids="5604" ext_dbs="" in_caption="True" ext_names="MAP2K1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">MEK1</sd-tag><sup>WT</sup> were used as an input control.</h5><p>Source data are available online for this figure.</p> <graphic href="https://api.sourcedata.io/file.php?panel_id=21494"/></sd-panel></fig><fig id="6954"><title>Patient-derived xenografts display similar resistance mechanisms as the parental metastases.</title><label>Figure 7</label><graphic href="https://api.sourcedata.io/file.php?figure_id=6954"/><sd-panel panel_id="21495"><sd-tag id="sdTag153" source="sdapi" category="assay" entity_type="None" role="None" text="Staining" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">Staining</sd-tag> <span>for <sd-tag id="sdTag151" source="sdapi" category="assay" entity_type="None" role="None" text="hematoxylin–eosin" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">hematoxylin-eosin</sd-tag> (<sd-tag id="sdTag156" source="sdapi" category="assay" entity_type="None" role="None" text="H&amp;E" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">H&amp;amp;amp;E</sd-tag>) and p-</span><sd-tag id="sdTag154" source="sdapi" category="None" entity_type="protein" role="assayed" text="ERK" ext_ids="P28482///P27361" ext_dbs="" in_caption="True" ext_names="MAPK1///MAPK3" ext_tax_ids="9606///9606" ext_tax_names="Homo sapiens///Homo sapiens" ext_urls="https://www.uniprot.org/uniprot////https://www.uniprot.org/uniprot/">ERK</sd-tag> on the PDX samples M032.X1, M032R1.X1, M032R2.X1, M032R4.X1, and M032R5.X1. Stainings showed that p-<sd-tag id="sdTag155" source="sdapi" category="None" entity_type="protein" role="assayed" text="ERK" ext_ids="P28482///P27361" ext_dbs="" in_caption="True" ext_names="MAPK1///MAPK3" ext_tax_ids="9606///9606" ext_tax_names="Homo sapiens///Homo sapiens" ext_urls="https://www.uniprot.org/uniprot////https://www.uniprot.org/uniprot/">ERK</sd-tag> is higher in the PDX derived from the resistant <span><sd-tag id="sdTag192" source="sdapi" category="None" entity_type="tissue" role="assayed" text="metastases" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">metastases</sd-tag></span>. Scale bar represents 100 μm. <graphic href="https://api.sourcedata.io/file.php?panel_id=21495"/></sd-panel><sd-panel panel_id="21496"><sd-tag id="sdTag158" source="sdapi" category="assay" entity_type="None" role="None" text="Immunoblotting" ext_ids="BAO_0002424" ext_dbs="" in_caption="True" ext_names="western blot" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">Immunoblotting</sd-tag> for components of the MAPK pathway confirmed reactivation of p-<sd-tag id="sdTag160" source="sdapi" category="None" entity_type="protein" role="assayed" text="ERK" ext_ids="P28482///P27361" ext_dbs="" in_caption="True" ext_names="MAPK1///MAPK3" ext_tax_ids="9606///9606" ext_tax_names="Homo sapiens///Homo sapiens" ext_urls="https://www.uniprot.org/uniprot////https://www.uniprot.org/uniprot/">ERK</sd-tag> in the PDX derived from the <sd-tag id="sdTag161" source="sdapi" category="None" entity_type="molecule" role="intervention" text="vemurafenib" ext_ids="CHEBI:63637" ext_dbs="" in_caption="True" ext_names="vemurafenib" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">vemurafenib</sd-tag>-resistant <span><sd-tag id="sdTag193" source="sdapi" category="None" entity_type="tissue" role="component" text="metastases" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">metastases</sd-tag></span>, although the p-<sd-tag id="sdTag162" source="sdapi" category="None" entity_type="protein" role="assayed" text="ERK" ext_ids="P28482///P27361" ext_dbs="" in_caption="True" ext_names="MAPK1///MAPK3" ext_tax_ids="9606///9606" ext_tax_names="Homo sapiens///Homo sapiens" ext_urls="https://www.uniprot.org/uniprot////https://www.uniprot.org/uniprot/">ERK</sd-tag> signal is heterogeneous in the pre-treatment PDX. <graphic href="https://api.sourcedata.io/file.php?panel_id=21496"/></sd-panel><sd-panel panel_id="21497"><p>Validation of the <sd-tag id="sdTag168" source="sdapi" category="None" entity_type="gene" role="assayed" text="BRAF" ext_ids="673" ext_dbs="" in_caption="True" ext_names="BRAF" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRAF</sd-tag> amplification was performed by <sd-tag id="sdTag169" source="sdapi" category="assay" entity_type="None" role="None" text="qPCR" ext_ids="BAO_0002084" ext_dbs="" in_caption="True" ext_names="real-time PCR " ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">qPCR</sd-tag> on gDNA derived from the PDX, using primers for <sd-tag id="sdTag171" source="sdapi" category="None" entity_type="gene" role="assayed" text="BRAF" ext_ids="673" ext_dbs="" in_caption="True" ext_names="BRAF" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRAF</sd-tag> and <sd-tag id="sdTag172" source="sdapi" category="None" entity_type="gene" role="assayed" text="CRAF" ext_ids="5894" ext_dbs="" in_caption="True" ext_names="RAF1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">CRAF</sd-tag> and normalized on LINE expression. Bars represent the mean of three replicates, error bars indicate standard deviation. The results confirmed that <sd-tag id="sdTag173" source="sdapi" category="None" entity_type="gene" role="assayed" text="BRAF" ext_ids="673" ext_dbs="" in_caption="True" ext_names="BRAF" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRAF</sd-tag> was amplified in PDX derived from M032R2 and M032R5, but not from M032R1.</p> <graphic href="https://api.sourcedata.io/file.php?panel_id=21497"/></sd-panel><sd-panel panel_id="21498"><p>Presence of the <sd-tag id="sdTag175" source="sdapi" category="None" entity_type="gene" role="assayed" text="MEK1" ext_ids="5604" ext_dbs="" in_caption="True" ext_names="MAP2K1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">MEK1</sd-tag><sup>T55delinsRT</sup> was analyzed by <sd-tag id="sdTag176" source="sdapi" category="assay" entity_type="None" role="None" text="PCR" ext_ids="BAO_0002080" ext_dbs="" in_caption="True" ext_names="polymerase chain reaction" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">PCR</sd-tag> using insertion-specific primers. As a control, primers amplifying exon 2 of <sd-tag id="sdTag177" source="sdapi" category="None" entity_type="gene" role="assayed" text="MEK1" ext_ids="5604" ext_dbs="" in_caption="True" ext_names="MAP2K1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">MEK1</sd-tag><sup>WT</sup> were used. The insertion was found in M032R1.X1 and M032R4.X1.</p> <graphic href="https://api.sourcedata.io/file.php?panel_id=21498"/></sd-panel></fig><fig id="6955"><title>Overview of all identified vemurafenib resistance mechanisms in patient and PDX samples.</title><label>Figure 8</label><graphic href="https://api.sourcedata.io/file.php?figure_id=6955"/><sd-panel panel_id="23657"><h5>Overview of all identified <sd-pretag id="sdPretag14600210810690" parent-tag-id="7">vemurafenib</sd-pretag> resistance mechanisms in <sd-pretag id="sdPretag14600211175650" parent-tag-id="4">patient</sd-pretag> and PDX samples</h5><p>Resistance mechanisms discovered in each of the lesions have been identified: a) in <sd-pretag id="sdPretag14600210453770" type="organism" role="experiment" category="null">patients</sd-pretag> samples by WES (<sd-pretag id="sdPretag14600210408980" parent-tag-id="21">BRAF</sd-pretag><sup>V600E</sup> amplification in M032R1, R2 and R5; <sd-pretag id="sdPretag14600210482570" parent-tag-id="47">MEK1</sd-pretag><sup>T55delinsRT</sup> in M032R4 and M032) and <sd-pretag id="sdPretag14600211023490" parent-tag-id="63">immunoblotting</sd-pretag> (of alternative form of <sd-pretag id="sdPretag14600210381290" parent-tag-id="21">BRAF</sd-pretag> in M032R3); and b) in PDX by <sd-pretag id="sdPretag14600211104920" type="null" role="null" category="assay">IHC</sd-pretag> and <sd-pretag id="sdPretag14600211194130" parent-tag-id="20">qPCR</sd-pretag> (<sd-pretag id="sdPretag14600211137520" parent-tag-id="21">BRAF</sd-pretag><sup>V600E</sup> amplification in M032R2 and R5) and <sd-pretag id="sdPretag14600210879240" parent-tag-id="46">PCR</sd-pretag> analysis (<sd-pretag id="sdPretag14600210994520" parent-tag-id="47">MEK1</sd-pretag><sup>T55delinsRT</sup> in M032R1 and R4). Gray arrows indicate that the lesion was at the back side. ampl., amplification; alt., alternative.</p> <graphic href="https://api.sourcedata.io/file.php?panel_id=23657"/></sd-panel></fig></article>